7 Results

People

  1. Adel
    Adel
  2. Harnicar
    Harnicar
  3. Mathew
    Mathew
  4. Barker
    Barker
  5. Devlin
    Devlin
  6. Giralt
    Giralt
  7. Kernan
    Kernan
  8. Ponce
    Ponce
  9. Pozotrigo
    Pozotrigo
  10. Scaradavou
    Scaradavou

Groups

  1. Center for Hematologic Malignancies (7)
  2. Clinical Pharmacy Specialists (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. Bone Marrow Transplant (6)
  6. Biostatistics Service (3)
  7. CTCR Scholars (3)
  8. Epidemiology and Biostatistics (3)
  9. MSK Grad Students (3)
  10. Master of Science in Clinical and Translational Cancer Research (3)
  1. "Nelly Adel"
  2. "Center for Hematologic Malignancies"
  3. "Sherry Mathew"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
Groups
  1. Center for Hematologic Malignancies (7)
  2. Clinical Pharmacy Specialists (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. Bone Marrow Transplant (6)
  6. Biostatistics Service (3)

More Groups

People
  1. Nelly Adel (7)
  2. Sherry Mathew (7)
  3. Stephen Harnicar (7)
  4. Andromachi Scaradavou (3)
  5. Doris Ponce (3)
  6. Juliet Barker (3)

More People

Years
  1. 2015 (1)
  2. 2014 (1)
  3. 2013 (1)
  4. 2012 (1)
  5. 2011 (2)
  6. 2010 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (4)
  2. Blood (2)
  3. Journal of Clinical Oncology (1)
Publishers
  1. Elsevier Inc. (4)
  2. American Society of Hematology (2)
  3. American Society of Clinical Oncology (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intensified mycophenolate mofetil dosing and higher mycophenolic acid trough levels reduce severe acute graft-versus-host disease after double-unit cord blood transplantation
    Journal Article

    Harnicar, S.; Ponce, D. M.; Hilden, P.; Zheng, J.; Devlin, S. M.; Lubin, M.; Pozotrigo, M.; Mathew, S.; Adel, N.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Higher mycophenolic acid (MPA) trough levels result in lower day 100 severe acute graft-versus-host disease (aGVHD) without increased toxicity in double-unit cord blood transplantation (CBT) recipients
    Meeting Abstract

    Harnicar, S.; Ponce, D. M.; Mathew, S.; Evans, K.; Zheng, J. T.; Devlin, S.; Pozotrigo, M.; Scaradavou, A.; Kernan, N. A.; Adel, N. G.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Higher mycophenolic acid (MPA) trough levels result in lower day 100 severe acute GVHD without increased toxicity in double-unit cord blood transplantation (CBT) recipients
    Meeting Abstract

    Harnicar, S. J.; Ponce, D. M.; Gregornik, D.; Mathew, S.; Evans, K. L.; Zheng, J.; Devlin, S.; Pozotrigo, M.; Scaradavou, A.; Kernan, N. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Safety and efficacy of dose escalated liposomal amphotericin B in adult leukemia patients with refractory invasive fungal infections: A single institution report
    Meeting Abstract

    Mathew, S.; Harnicar, S.; Halton, E.; Berman, E.; Brentjens, R. J.; Heaney, M. L.; Jurcic, J. G.; Lamanna, N.; Maslak, P. G.; Rosenblat, T. L.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Retrospective comparison of phenytoin and levetiracetam as seizure prophylaxis with high dose busulfan during allogeneic stem cell transplant
    Meeting Abstract

    Mathew, S.; Harnicar, S.; Adel, N.; Papadopoulos, E.
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • Management strategies for allogeneic hematopoetic stem cell transplant (HSCT) graft verus host disease (GVHD) prophylaxis in the setting of calcineurin inhibitor (CNI) toxicity
    Meeting Abstract

    Harnicar, S.; Mathew, S.; Adel, N.; Giralt, S.; Jakubowski, A.
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • High number of successful mobilizations associated with the use of plerixafor and colony stimulating factors in patients with multiple myeloma (MM) and lymphoma treated at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Adel, N. G.; Mathew, S.; Harnicar, S. J.; Mccullagh, E.; Landau, H.; Giralt, S.; Vanak, J.; Chimento, D.; Lucarelli, C.; Matasar, M. J.; more...
    Blood (2010)

    Fulltext@MSK | Save